Your Cart ( 2 Items )

• Deucravacitinib for Moderate-to-Severe Psoriasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  February 2024 | Volume 23 | Issue 2 | Original Article | 67 | Copyright © February 2024
  Otavio A.S. Toth ^a, Patrick F. Meldola ^a, Pablo G. Machado ^a, Gabriel F.C. Chiarelli ^a, Erick Schnorrenberger ^a, Jose L. S. Kracik ^a, Caio C. de Carvalho ^a, Joao V. L. Guzatti ^a, Philip J. Mease MD MACR^b
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs
• Rapid Onset of Action in Patients With Moderate-to-Severe Plaque Psoriasis With Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination
  August 2018 | Volume 17 | Issue 8 | Original Article | 863 | Copyright © August 2018
  Linda Stein Gold MD,^a Leon H. Kircik MD,^b David Pariser MD,^c Jeffrey L. Sugarman MD PhD,^d Tina Lin PharmD,^e Robert Kang MS,^f Radhakrishnan Pillai PhD^g
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs